These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 11767079)
21. Formulation and characterization of a compacted multiparticulate system for modified release of water-soluble drugs--Part II theophylline and cimetidine. Cantor SL; Hoag SW; Augsburger LL Drug Dev Ind Pharm; 2009 May; 35(5):568-82. PubMed ID: 18979306 [TBL] [Abstract][Full Text] [Related]
22. Properties of hot-melt extruded theophylline tablets containing poly(vinyl acetate). Zhang F; McGinity JW Drug Dev Ind Pharm; 2000 Sep; 26(9):931-42. PubMed ID: 10914317 [TBL] [Abstract][Full Text] [Related]
23. Formulation and evaluation of a pulsatile drug delivery system using time- and pH-dependant polymers. Kadam VD; Gattani SG Pharm Dev Technol; 2010; 15(1):57-63. PubMed ID: 19552544 [TBL] [Abstract][Full Text] [Related]
24. Development of enteric-coated pectin-based matrix tablets for colonic delivery of theophylline. Mura P; Maestrelli F; Cirri M; González Rodríguez ML; Rabasco Alvarez AM J Drug Target; 2003 Jul; 11(6):365-71. PubMed ID: 14668057 [TBL] [Abstract][Full Text] [Related]
25. Preparation of floating drug delivery system by plasma technique. Nakagawa T; Kondo S; Sasai Y; Kuzuya M Chem Pharm Bull (Tokyo); 2006 Apr; 54(4):514-8. PubMed ID: 16595955 [TBL] [Abstract][Full Text] [Related]
26. Near-infrared spectroscopic analysis of the breaking force of extended-release matrix tablets prepared by roller-compaction: influence of plasticizer levels and sintering temperature. Dave VS; Fahmy RM; Hoag SW Drug Dev Ind Pharm; 2015 Jun; 41(6):898-905. PubMed ID: 24785574 [TBL] [Abstract][Full Text] [Related]
27. Antibacterial Nanofibrous Mats Composed of Eudragit for pH-Dependent Dissolution. Son YJ; Kim Y; Kim WJ; Jeong SY; Yoo HS J Pharm Sci; 2015 Aug; 104(8):2611-8. PubMed ID: 26053132 [TBL] [Abstract][Full Text] [Related]
28. Insights into the mechanisms of chitosan-anionic polymers-based matrix tablets for extended drug release. Li L; Wang L; Li J; Jiang S; Wang Y; Zhang X; Ding J; Yu T; Mao S Int J Pharm; 2014 Dec; 476(1-2):253-65. PubMed ID: 25290814 [TBL] [Abstract][Full Text] [Related]
29. Development of enteric-coated fixed dose combinations of amorphous solid dispersions of ezetimibe and lovastatin: Investigation of formulation and process parameters. Riekes MK; Dereymaker A; Berben P; Augustijns P; Stulzer HK; Van den Mooter G Int J Pharm; 2017 Mar; 520(1-2):49-58. PubMed ID: 28153650 [TBL] [Abstract][Full Text] [Related]
30. Effect of drug-polymer interaction on the release characteristics of methacrylic acid copolymer microcapsules containing theophylline. Hsiue GH; Liao CM; Lin SY Artif Organs; 1998 Aug; 22(8):651-6. PubMed ID: 9702316 [TBL] [Abstract][Full Text] [Related]
31. Effect of the molecular size of carboxymethylcellulose and some polymers on the sustained release of theophylline from a hydrophilic matrix. Emeje MO; Kunle OO; Ofoefule SI Acta Pharm; 2006 Sep; 56(3):325-35. PubMed ID: 19831281 [TBL] [Abstract][Full Text] [Related]
32. The effect of tablet formulation and hardness on in vitro release of cephalexin from Eudragit L100 based extended release tablets. Saravanan M; Nataraj KS; Ganesh KS Biol Pharm Bull; 2002 Apr; 25(4):541-5. PubMed ID: 11995942 [TBL] [Abstract][Full Text] [Related]
33. Statistical optimization of indomethacin pellets coated with pH-dependent methacrylic polymers for possible colonic drug delivery. Akhgari A; Afrasiabi Garekani H; Sadeghi F; Azimaie M Int J Pharm; 2005 Nov; 305(1-2):22-30. PubMed ID: 16236475 [TBL] [Abstract][Full Text] [Related]
34. Design and evaluation of pH modulated controlled release matrix systems for colon specific delivery of indomethacin. Asghar LF; Chandran S Pharmazie; 2008 Oct; 63(10):736-42. PubMed ID: 18972836 [TBL] [Abstract][Full Text] [Related]
35. Suitability of κ-carrageenan pellets for the formulation of multiparticulate tablets with modified release. Ghanam D; Kleinebudde P Int J Pharm; 2011 May; 409(1-2):9-18. PubMed ID: 21335073 [TBL] [Abstract][Full Text] [Related]
36. A novel powder coating process for attaining taste masking and moisture protective films applied to tablets. Cerea M; Zheng W; Young CR; McGinity JW Int J Pharm; 2004 Jul; 279(1-2):127-39. PubMed ID: 15234801 [TBL] [Abstract][Full Text] [Related]
37. Film-coated matrix mini-tablets for the extended release of a water-soluble drug. Mohamed FA; Roberts M; Seton L; Ford JL; Levina M; Rajabi-Siahboomi AR Drug Dev Ind Pharm; 2015 Apr; 41(4):623-30. PubMed ID: 24564797 [TBL] [Abstract][Full Text] [Related]
38. Comparative evaluation of interpolyelectrolyte complexes of chitosan with Eudragit L100 and Eudragit L100-55 as potential carriers for oral controlled drug delivery. Moustafine RI; Margulis EB; Sibgatullina LF; Kemenova VA; Van den Mooter G Eur J Pharm Biopharm; 2008 Sep; 70(1):215-25. PubMed ID: 18691856 [TBL] [Abstract][Full Text] [Related]
39. Improved drug delivery to the lower intestinal tract with tablets compression-coated with enteric/nonenteric polymer powder blends. Rujivipat S; Bodmeier R Eur J Pharm Biopharm; 2010 Nov; 76(3):486-92. PubMed ID: 20868750 [TBL] [Abstract][Full Text] [Related]
40. Influence of an acrylic polymer blend on the physical stability of film-coated theophylline pellets. Kucera S; Shah NH; Malick AW; Infeld MH; McGinity JW AAPS PharmSciTech; 2009; 10(3):864-71. PubMed ID: 19568939 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]